Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 46%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is a strong player in the chronic conditions market due to its specialized care tracks and successful outcomes, leading to potential growth and profitability. However, competition and potential risks should also be considered. With predictable revenue and high margins, as well as a strong go-to-market strategy and partnerships, the company's overall outlook remains positive with a buy rating.

Bears say

Omada Health is set to continue delivering measurable health outcomes and value, but long-term margin projections and a current discount to peers suggest potential challenges in expanding their foothold in the market. While impressive retention rates, extensive market outreach, and comprehensive product offerings provide a competitive advantage, these strengths may not be enough to maintain OMDA's current valuation. Additionally, with only ~30% of the population having multiple conditions and the potential for competitors to enter the space, the growth trajectory may not reach its full potential.

OMDA has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 46% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 13 analysts, OMDA has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.85, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.85, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.